{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:20:56Z","timestamp":1791188456714,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jaad.2009.06.050","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:58:20Z","timestamp":1263517100000},"page":"205-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":364,"title":["Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial"],"prefix":"10.1016","volume":"62","author":[{"given":"Annika","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayler","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael O.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Kerdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.06.050_bib1","series-title":"Hidradenitis suppurativa","first-page":"11","article-title":"Clinical presentation","author":"Poli","year":"2006"},{"key":"10.1016\/j.jaad.2009.06.050_bib2","series-title":"Hidradenitis suppurativa","year":"2006"},{"key":"10.1016\/j.jaad.2009.06.050_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1745-7599.2007.00219.x","article-title":"Current understanding and management of hidradenitis suppurativa","volume":"19","author":"Krbec","year":"2007","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/j.jaad.2009.06.050_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.jid.5700272","article-title":"Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3","volume":"126","author":"Gao","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Von Der Werth","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1985.tb02037.x","article-title":"Evidence of genetic factors in hidradenitis suppurativa","volume":"113","author":"Fitzsimmons","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1699-0463.1997.tb00584.x","article-title":"The homogeneity of hidradenitis suppurativa lesions: a histological study of intra-individual variation","volume":"105","author":"Jemec","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/j.jaad.2009.06.050_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1468-3083.2001.00303.x","article-title":"Acne inversa (alias hidradenitis suppurativa)","volume":"15","author":"Jansen","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.06.050_bib9","series-title":"Hidradenitis suppurativa","first-page":"86","article-title":"Bacteriology of hidradenitis suppurativa","author":"Oprica","year":"2006"},{"key":"10.1016\/j.jaad.2009.06.050_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2133.1996.d01-1069.x","article-title":"Hidradenitis suppurativa or acne inversa: a clinicopathological study of early lesions","volume":"135","author":"Boer","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib13","series-title":"Acne and related disorders","article-title":"The prevalence of hidradenitis suppurativa in South Wales","author":"Harrison","year":"1988"},{"key":"10.1016\/j.jaad.2009.06.050_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1517\/14656566.5.8.1767","article-title":"Medical treatment of hidradenitis suppurativa","volume":"5","author":"Jemec","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2009.06.050_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.jaad.2009.06.050_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.surg.2005.06.053","article-title":"Surgical treatment of hidradenitis suppurativa: a 10-year experience","volume":"138","author":"Kagan","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.jaad.2009.06.050_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.06.050_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00063030-200216020-00005","article-title":"Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis","volume":"16","author":"Keating","year":"2002","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaad.2009.06.050_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","article-title":"Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial","volume":"51","author":"Gottlieb","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2009.06.050_bib22","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.06.050_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/120347540400800202","article-title":"A review of the use of infliximab to manage cutaneous dermatoses","volume":"8","author":"Gupta","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2009.06.050_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.06.050_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.53.1.64","article-title":"Arthritis associated with hidradenitis suppurativa","volume":"53","author":"Bhalla","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.06.050_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09546630410024547","article-title":"Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease","volume":"16","author":"Rosi","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.06.050_bib27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00535-003-1185-9","article-title":"Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy","volume":"38","author":"Roussomoustakaki","year":"2003","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.06.050_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2249.1993.tb03457.x","article-title":"Localization of tumor necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor","volume":"94","author":"Kristensen","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2009.06.050_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cgh.2007.02.016","article-title":"Serious adverse events with infliximab: analysis of spontaneously reported adverse events","volume":"5","author":"Hansen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.06.050_bib33","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib36","unstructured":"Drucker AM, Winkelman WJ, Walsh S, Shear NH. Long term experience with infliximab in hidradenitis suppurativa and pyroderma gangrenosum: a case series of 9 patients. Presented orally at: Canadian Dermatology Association 83rd Annual Conference, June 2008, Montreal."},{"key":"10.1016\/j.jaad.2009.06.050_bib37","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(05)67566-6","article-title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicenter, double-blind trial","volume":"366","author":"Reich","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.06.050_bib38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2006.07.017","article-title":"A randomized comparison of continuous vs intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis","volume":"56","author":"Menter","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib39","first-page":"1538","article-title":"Infliximab dose and clinical status: results of 2 studies in 1642 patients with rheumatoid arthritis","volume":"31","author":"Stern","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a\u00a0simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2009.06.050_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000102032","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"215","author":"Fernandez-Vozmediano","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.06.050_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0151-9638(07)91613-0","article-title":"Modifications to the Sartorius score and instructions for evaluating the severity of suppurative hidradenitis","volume":"134","author":"Revuz","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.06.050_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib47","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","article-title":"Mediation of hidradenitis suppurativa by androgens","volume":"292","author":"Mortimer","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jaad.2009.06.050_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/014107680009300808","article-title":"Hidradenitis suppurativa","volume":"93","author":"Mortimer","year":"2000","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2009.06.050_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.annder.2008.03.003","article-title":"The role of surgery in the treatment of hidradenitis suppurativa","volume":"135","author":"Revuz","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.06.050_bib51","article-title":"Cyclosporin-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2009.06.050_bib52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib54","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archderm.142.9.1110","article-title":"The cutting edge: severe hidradenitis suppurativa treated with adalimumab","volume":"142","author":"Moul","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.06.050_bib55","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.06.050_bib56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMoa020888","article-title":"Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease","volume":"348","author":"Baert","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209007828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209007828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:15:50Z","timestamp":1759270550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209007828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0190962209007828"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.06.050","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2567956.2306057","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.2567956.2220054","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.06.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}